NasdaqGM - Nasdaq Real Time Price
USD
TScan Therapeutics, Inc. (TCRX)
0.1880
+0.0062
(+3.41%)
At close: November 6 at 4:00:01 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP Beneficial Owner of more than 10% of a Class of Security |
Purchase | Dec 23, 2025 | -- |
| MACBEATH GAVIN Chief Executive Officer |
Stock Award(Grant) | Oct 1, 2026 | 1,049,770 |
| ZDRAVESKI ZORAN Officer |
Stock Award(Grant) | Oct 1, 2026 | 304,716 |
